Efficacy and safety profiles of manidipine compared with amlodipine: A meta-analysis of head-to-head trials
2011

Comparing Manidipine and Amlodipine for Blood Pressure Management

Sample size: 838 publication Evidence: high

Author Information

Author(s): Richy Florent, Laurent Stephane

Primary Institution: University of Liege Faculty of Medicine, Belgium

Hypothesis

Ankle oedema would occur to a lesser extent after manidipine than after amlodipine, despite a similar antihypertensive efficacy.

Conclusion

Manidipine is associated with significantly less ankle oedema and total adverse events compared to amlodipine, despite similar blood pressure-lowering efficacy.

Supporting Evidence

  • Manidipine showed a relative risk of 0.69 for total adverse events compared to amlodipine.
  • The pooled relative risk for developing ankle oedema was 0.35 for manidipine against amlodipine.
  • Both drugs had statistically similar efficacy in lowering blood pressure.

Takeaway

This study found that manidipine is better than amlodipine because it causes fewer side effects, especially swelling in the ankles, while still helping to lower blood pressure.

Methodology

A meta-analysis of head-to-head randomized controlled trials comparing manidipine and amlodipine was conducted, focusing on blood pressure changes and adverse events.

Potential Biases

Potential publication bias was assessed and found not to significantly affect the results.

Limitations

The study may be biased by selective publication of positive trials, and RCTs may not identify rare adverse events due to limited power.

Participant Demographics

Patients aged over 35 years with mild to moderate hypertension.

Statistical Information

P-Value

0.001

Confidence Interval

0.56–0.85

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3109/08037051.2010.518670

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication